Healthpeak Properties, Inc. (DOC) Insider Trading

Last 12 months

Insiders sold $214k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. CDO and Head of Lab Scott R Bohn sold $214k on May 12, 59% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market

−$214k

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

Aug 2025

Aug 6, 2025

Get an email when DOC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
May 12	Scott R Bohn CDO and Head of Lab	SoldNo plan	10,989	$19.45	$214k	59%	Form 4
Aug 6, 2025	John T Thomas Director	Bought	1,450	$17.06	$25k	0.2%	Form 4
Aug 4, 2025	Scott M Brinker President and CEO	Bought	1,490	$16.83	$25k	0.7%	Form 4
Jul 31, 2025	Scott M Brinker President and CEO	Bought	2,930	$17.06	$50k	1.4%	Form 4
Jul 28, 2025	Scott M Brinker President and CEO	Bought	2,873	$17.40	$50k	1.4%	Form 4
May 28, 2025	Tommy G Thompson Director	Bought	5,777	$17.27	$100k	4.2%	Form 4
May 9, 2025	Tommy G Thompson Director	Bought	5,700	$17.36	$99k	4.3%	Form 4
May 9, 2025	Scott M Brinker President and CEO	Bought	2,750	$17.39	$48k	1.4%	Form 4
Apr 29, 2025	Ava Lias-Booker Director	Bought	5,000	$17.83	$89k	16%	Form 4
Apr 28, 2025	John T Thomas Director	Bought	4,200	$17.84	$75k	0.5%	Form 4
Apr 28, 2025	Katherine M Sandstrom Director	Bought	11,288	$17.65	$199k	25%	Form 4
Apr 28, 2025	Sara Grootwassink Lewis Director	Bought	6,000	$17.66	$106k	9.8%	Form 4
Apr 28, 2025	Pamela Shelley-Kessler Director	Bought 2 parts	2,838	$17.62 average	$50k	6.7%	Form 4
Apr 28, 2025	Scott M Brinker President and CEO	Bought	11,337	$17.68	$200k	6.0%	Form 4

May 12No plan
Scott R Bohn
CDO and Head of Lab · sold 10,989 at $19.45
$214k
59% of stake
Aug 6, 2025
John T Thomas
Director · bought 1,450 at $17.06
$25k
0.2% of stake
Aug 4, 2025
Scott M Brinker
President and CEO · bought 1,490 at $16.83
$25k
0.7% of stake
Jul 31, 2025
Scott M Brinker
President and CEO · bought 2,930 at $17.06
$50k
1.4% of stake
Jul 28, 2025
Scott M Brinker
President and CEO · bought 2,873 at $17.40
$50k
1.4% of stake
May 28, 2025
Tommy G Thompson
Director · bought 5,777 at $17.27
$100k
4.2% of stake
May 9, 2025
Tommy G Thompson
Director · bought 5,700 at $17.36
$99k
4.3% of stake
May 9, 2025
Scott M Brinker
President and CEO · bought 2,750 at $17.39
$48k
1.4% of stake
Apr 29, 2025
Ava Lias-Booker
Director · bought 5,000 at $17.83
$89k
16% of stake
Apr 28, 2025
John T Thomas
Director · bought 4,200 at $17.84
$75k
0.5% of stake
Apr 28, 2025
Katherine M Sandstrom
Director · bought 11,288 at $17.65
$199k
25% of stake
Apr 28, 2025
Sara Grootwassink Lewis
Director · bought 6,000 at $17.66
$106k
9.8% of stake
Apr 28, 2025
Pamela Shelley-Kessler
Director · bought 2,838 at avg $17.62
$50k
6.7% of stake
Apr 28, 2025
Scott M Brinker
President and CEO · bought 11,337 at $17.68
$200k
6.0% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DOC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Real Estate Investment Trusts

SBACSba Communications Corp

AREAlexandria Real Estate Equities, Inc.

AVBAvalonbay Communities Inc

RHPRyman Hospitality Properties, Inc.

COLDAmericold Realty Trust

AHRAmerican Healthcare REIT, Inc.

CXWCoreCivic Inc.

EXRExtra Space Storage Inc.

Spot a number that looks wrong? Check it in DOC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DOC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.